492TiP A phase I study of synthetic lethal, IDE397 (MAT2A inhibitor) as a monotherapy and in combination with chemotherapy in advanced solid tumors harboring MTAP deletion

Authors:
  • MJM.L. Johnson
    M.L. Johnson
  • JRJ. Rodon
    J. Rodon
  • RAR. Aljumaily
    R. Aljumaily
  • MVM. Villalona-Calero
    M. Villalona-Calero
  • EBE. Borazanci
    E. Borazanci
  • MPM. Pishvaian
    M. Pishvaian
  • ATA. Turk
    A. Turk
  • RCR.D. Carvajal
    R.D. Carvajal
  • CMC. Mantia
    C. Mantia
  • GGG. Giaccone
    G. Giaccone
  • ZMZ. Mounir
    Z. Mounir
  • APA. Patel
    A. Patel

Abstract
No abstract available